MDS clinical diagnostic criteria for Parkinson’s disease

Postuma, Ronald B., Berg, Daniela, Stern, Matthew, Poewe, Werner, Olanow, C. Warren, Oertel, Wolfgang, Obeso, José, Marek, Kenneth +10 more·2015·Movement Disorders

DOI 10.1002/mds.26424

Cited by (1,019)

Items 801–900 of 1,019

EEG Microstates Change in Response to Increase in Dopaminergic Stimulation in Typical Parkinson’s Disease Patients
José Ignacio Serrano, María Dolores del Castillo, Verónica Cortés, Nuno Mendes, Aída Arroyo-Ferrer, Jorge Andreo-Jover, Eduardo Rocón, Maria Del Valle, Jaime Herreros Rodríguez, Juan Pablo Romero · 2018 · Frontiers in Neuroscience
Glutamine protects against oxidative stress injury through inhibiting the activation of PI3K/Akt signaling pathway in parkinsonian cell model
Yingqian Zhao, Qiang Wang, Yuan Wang, Jie Li, Gang Lu, Zhibin Liu · 2019 · Environmental Health and Preventive Medicine
Correlations between dopaminergic dysfunction and abnormal metabolic network activity in REM sleep behavior disorder
Zhemin Huang, Chengfeng Jiang, Ling Li, Qian Xu, Jingjie Ge, Ming Li, Yihui Guan, Jianjun Wu, Jian Wang, Chuantao Zuo et al. · 2019 · Journal of Cerebral Blood Flow & Metabolism
Ultrasonication-based rapid amplification of α-synuclein aggregates in cerebrospinal fluid
Keita Kakuda, Kensuke Ikenaka, Katsuya Araki, Masatomo So, César Aguirre, Yuta Kajiyama, Kuni Konaka, Kentaro Noi, Kousuke Baba, Hiroshi Tsuda et al. · 2019 · Scientific Reports
Designing a mHealth clinical decision support system for Parkinson’s disease: a theoretically grounded user needs approach
Lada Timotijević, Charo Elena Hodgkins, Adrian P. Banks, Patrice Rusconi, Bernadette Egan, M. Peacock, Ellen Seiss, Morro Touray, Heather Gage, Clelia Pellicano et al. · 2020 · BMC Medical Informatics and Decision Making
Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease—Viewpoint
Carolina Sportelli, Daniele Urso, Peter G. Jenner, К. Ray Chaudhuri · 2020 · Frontiers in Neurology
Plasma immune markers in an idiopathic REM sleep behavior disorder cohort
Hui Zhang, Ting Wang, Yuan Li, Wei Mao, Shuwen Hao, Zhaoyang Huang, Piu Chan, Yanning Cai · 2020 · Parkinsonism & Related Disorders
A double-blind randomized controlled trial of the efficacy of cognitive training delivered using two different methods in mild cognitive impairment in Parkinson’s disease: preliminary report of benefits associated with the use of a computerized tool
Sara Bernini, Silvia Panzarasa, Marica Barbieri, Elena Sinforiani, Silvana Quaglini, Cristina Tassorelli, Sara Bottiroli · 2020 · Aging Clinical and Experimental Research
Cerebrospinal α‐Synuclein Oligomers Reflect Disease Motor Severity in DeNoPa Longitudinal Cohort
Nour K. Majbour, Ilham Y. Abdi, Mohammed Dakna, Tamara Wicke, Elisabeth Lang, Houda Yasmine Ali Moussa, Mercy A. Thomas, Claudia Trenkwalder, Bared Safieh‐Garabedian, Takahiko Tokuda et al. · 2021 · Movement Disorders
Fibroblast Growth Factor 21 Modulates Microglial Polarization That Attenuates Neurodegeneration in Mice and Cellular Models of Parkinson's Disease
Changwei Yang, Wuqiong Wang, Pengxi Deng, Chen Li, Liangcai Zhao, Hongchang Gao · 2021 · Frontiers in Aging Neuroscience
GBA mutations, glucosylceramide and Parkinson's disease
Ivan Milenković, Shani Blumenreich, Anthony H. Futerman · 2021 · Current Opinion in Neurobiology
Synucleinopathies
Elizabeth A. Coon, Wolfgang Singer · 2020 · CONTINUUM Lifelong Learning in Neurology
Imaging of Substantia Nigra in Parkinson’s Disease: A Narrative Review
Paola Feraco, Cesare Gagliardo, Giuseppe La Tona, Eleonora Bruno, Costanza D’Angelo, Maurizio Marrale, Anna Del Poggio, Maria Chiara Malaguti, Laura Geraci, Roberta Baschi et al. · 2021 · Brain Sciences
Machine learning trained with quantitative susceptibility mapping to detect mild cognitive impairment in Parkinson's disease
Haruto Shibata, Yuto Uchida, Shohei Inui, Hirohito Kan, Keita Sakurai, Naoya Oishi, Yoshino Ueki, Kenichi Oishi, Noriyuki Matsukawa · 2021 · Parkinsonism & Related Disorders
Does Olfactory Dysfunction Correlate with Disease Progression in Parkinson’s Disease? A Systematic Review of the Current Literature
Tommaso Ercoli, Carla Masala, Gianluca Cadeddu, Marcello Mario Mascia, Gianni Orofino, Angelo Fabio Gigante, Paolo Solla, Giovanni Defazio, Lorenzo Rocchi · 2022 · Brain Sciences
α‐Synuclein V15A Variant in Familial Parkinson's Disease Exhibits a Weaker Lipid‐Binding Property
Kensuke Daida, S. Shimonaka, Kahori Shiba-Fukushima, J. Ogata, H. Yoshino, A. Okuzumi, T. Hatano, Y. Motoi, Tomoki Hirunagi, M. Katsuno et al. · 2022 · Movement Disorders
Epigenome-wide association study of human frontal cortex identifies differential methylation in Lewy body pathology
Lasse Pihlstrøm, Gemma L. Shireby, Hanneke Geut, Sandra Pilar Henriksen, Annemieke J.M. Rozemüller, Jon‐Anders Tunold, Eilis J. Hannon, Paul T. Francis, Alan J. Thomas, Seth Love et al. · 2022 · Nature Communications
Noninvasive neuroimaging provides evidence for deterioration of the glymphatic system in Parkinson's disease relative to essential tremor
Luyan Gu, Shaobing Dai, Tao Guo, Xiaoli Si, Dayao Lv, Zhiyun Wang, Jinyu Lu, Yi Fang, Xiaojun Guan, Cheng Zhou et al. · 2022 · Parkinsonism & Related Disorders
Common and distinct roles of amygdala subregional functional connectivity in non-motor symptoms of Parkinson’s disease
Junling Wang, Lianglong Sun, Lili Chen, Junyan Sun, Yapei Xie, Dezheng Tian, Linlin Gao, Dongling Zhang, Mingrui Xia, Tao Wu · 2023 · npj Parkinson s Disease
Feasibility and usability of a digital health technology system to monitor mobility and assess medication adherence in mild-to-moderate Parkinson's disease
Héloïse Debelle, Emma Packer, Esther Beales, Harry G. B. Bailey, Ríona Mc Ardle, Philip M. Brown, Heather Hunter, Fabio Ciravegna, Neil Ireson, Jordi Evers et al. · 2023 · Frontiers in Neurology
Identification of Parkinson’s disease and multiple system atrophy using multimodal PET/MRI radiomics
Jinju Sun, Cong Chao, Xinpeng Li, Weicheng Zhou, Renxiang Xia, Huan Liu, Yi Wang, Zhiqiang Xu, Xingfei Chen · 2023 · European Radiology
Comparison of biospecimens for α‐synuclein seed amplification assays in Parkinson's disease: A systematic review and network meta‐analysis
Yuanchu Zheng, Siming Li, Yang Chen, Zhenwei Yu, Ying Jiang, Tao Feng · 2023 · European Journal of Neurology
The rise of Parkinson’s disease is a global challenge, but efforts to tackle this must begin at a national level: a protocol for national digital screening and “eat, move, sleep” lifestyle interventions to prevent or slow the rise of non-communicable diseases in Thailand
Roongroj Bhidayasiri, Jirada Sringean, Saisamorn Phumphid, Chanawat Anan, Chusak Thanawattano, Suwijak Deoisres, Pattamon Panyakaew, Onanong Phokaewvarangkul, Suppata Maytharakcheep, Vijittra Buranasrikul et al. · 2024 · Frontiers in Neurology
GBA1-Associated Parkinson’s Disease Is a Distinct Entity
Aliaksandr Skrahin, Mia Horowitz, Majdolen Istaiti, Volha Skrahina, Jan Lukáš, Gilad Yahalom, Mikhal E. Cohen, Shoshana Revel‐Vilk, Özlem Göker-Alpan, Michal Becker‐Cohen et al. · 2024 · International Journal of Molecular Sciences
A quantitative Lewy-fold-specific alpha-synuclein seed amplification assay as a progression marker for Parkinson’s disease
Alexander Maximilian Bernhardt, Sebastian Longen, Svenja Verena Trossbach, Marcello Rossi, Daniel Weckbecker, Felix Schmidt, Alexander Jäck, Sabrina Katzdobler, Urban M. Fietzek, Endy Weidinger et al. · 2025 · Acta Neuropathologica
Comparative analysis of Parkinson’s and inflammatory bowel disease gut microbiomes reveals shared butyrate-producing bacteria depletion
Maeve E. Krueger, Jake Sondag Boles, Zachary D Simon, Stephan D. Alvarez, Nikolaus R. McFarland, Michael S. Okun, Ellen M. Zimmermann, Chris E. Forsmark, Malú G. Tansey · 2025 · npj Parkinson s Disease
Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases
Sandy S. C. Hung, Shahnaz Khan, Camden Yeung-Wah Lo, Alex William Hewitt, Raymond C.B. Wong · 2017 · Pharmacology & Therapeutics
Emerging Biosensing Technologies for Neuroinflammatory and Neurodegenerative Disease Diagnostics
Catarina M. Abreu, Ricardo Soares-dos-Reis, Pedro Melo, João Bettencourt Relvas, Joana Guimarães, María José Sá, Andrea Cruz, Inês Mendes Pinto · 2018 · Frontiers in Molecular Neuroscience
Cognition among individuals along a spectrum of increased risk for Parkinson’s disease
Lana M. Chahine, Liz Urbe, Chelsea Caspell‐Garcia, Dag Aarsland, Roy N. Alcalay, Paolo Barone, David John Burn, Alberto Javier Espay, Jamie L. Hamilton, Keith A. Hawkins et al. · 2018 · PLoS ONE
The prodromes of Parkinson's disease
Richard Nathaniel Rees, Alastair John Noyce, Anette E. Schrag · 2018 · European Journal of Neuroscience
Apelin-36 exerts the cytoprotective effect against MPP+-induced cytotoxicity in SH-SY5Y cells through PI3K/Akt/mTOR autophagy pathway
Junge Zhu, Shanshan Dou, Yunlu Jiang, Bo Bai, Jing Chen, Chunmei Wang, Baohua Cheng · 2019 · Life Sciences
PET Imaging of Astrogliosis and Tau Facilitates Diagnosis of Parkinsonian Syndromes
Sonja Schönecker, M. Brendel, C. Palleis, L. Beyer, G. Höglinger, E. Schuh, B. Rauchmann, J. Sauerbeck, G. Rohrer, S. Sonnenfeld et al. · 2019 · Frontiers in Aging Neuroscience
Diagnosis and Differential Diagnosis of Parkinson Disease
Stefano Caproni, Carlo Colosimo · 2019 · Clinics in Geriatric Medicine
ALFF and ReHo Mapping Reveals Different Functional Patterns in Early- and Late-Onset Parkinson’s Disease
Yumei Yue, Yasi Jiang, Ting Shen, Jiali Pu, Hsin‐Yi Lai, Baorong Zhang · 2020 · Frontiers in Neuroscience
Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?
Florin Gandor, Annemarie Vogel, Inga Claus, Sigrid Ahring, Doreen Gruber, Hans‐Jochen Heinze, Rainer Dziewas, Georg Ebersbach, Tobias Warnecke · 2020 · Movement Disorders
Olfactory dysfunction in frontotemporal dementia and psychiatric disorders: A systematic review
Sarah Ellen Carnemolla, Julien Wen Hsieh, Rebecca Sipione, Basile Nicolas Landis, Fiona Kumfor, Olivier Piguet, Aurélie L. Manuel · 2020 · Neuroscience & Biobehavioral Reviews
VPS35 and the mitochondria: Connecting the dots in Parkinson's disease pathophysiology
Gianni Cutillo, David K. Simon, Simona Eleuteri · 2020 · Neurobiology of Disease
Is Levodopa Response a Valid Indicator of Parkinson's Disease?
W. R. Wayne Martin, Michael Miles, Qiaonan Zhong, Johanna M Hartlein, Brad Alan Racette, Scott A. Norris, Mwiza Ushe, Baijayanta Maiti, Susan R. Criswell, Albert A. Davis et al. · 2020 · Movement Disorders
Using Artificial Neural Network to Discriminate Parkinson’s Disease from Other Parkinsonisms by Focusing on Putamen of Dopamine Transporter SPECT Images
Chung-Yao Chien, Szu-Wei Hsu, Tsung-Lin Lee, Pi‐Shan Sung, Chou‐Ching K. Lin · 2020 · Biomedicines
Alteration of brain structural connectivity in progression of Parkinson's disease: A connectome-wide network analysis
Yanwu Yang, Chenfei Ye, Junyan Sun, Liang Li, Haiyan Lv, Linlin Gao, Jiliang Fang, Ting Ma, Tao Wu · 2021 · NeuroImage Clinical
Mild Parkinsonian Signs: A Systematic Review of Clinical, Imaging, and Pathological Associations
Sarah M. Buchanan, Marcus Richards, Jonathan M. Schott, Anette E. Schrag · 2021 · Movement Disorders
Insights into the multifaceted role of circular RNAs: implications for Parkinson’s disease pathogenesis and diagnosis
Epaminondas Doxakis · 2022 · npj Parkinson s Disease
LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease
Eunice Eun Seo Chang, Philip Wing‐Lok Ho, Huifang Liu, Shirley Yin-Yu Pang, Chi-Ting Leung, Yasine Malki, Zoe Yuen-Kiu Choi, David Boyer Ramsden, Shu‐Leong Ho · 2022 · Translational Neurodegeneration
<i>GALC</i> variants affect galactosylceramidase enzymatic activity and risk of Parkinson’s disease
Senkevich, Konstantin, Zorca, Cornelia E, Dworkind, Aliza, Rudakou, Uladzislau, Somerville, Emma, Yu, Eric, Ermolaev, Alexey, Nikanorova, Daria, Ahmad, Jamil, Ruskey, Jennifer A et al. · 2023 · Brain
Employing nanoparticle tracking analysis of salivary neuronal exosomes for early detection of neurodegenerative diseases
Vaibhav Sharma, Fredrik K. Nikolajeff, Saroj Kumar · 2023 · Translational Neurodegeneration
Agricultural paraquat dichloride use and Parkinson’s disease in California’s Central Valley
Kimberly C. Paul, Myles Cockburn, Yufan Gong, Jeff M. Bronstein, Beate R. Ritz · 2024 · International Journal of Epidemiology
Plasticity‐Induced Effects of Theta Burst Transcranial Ultrasound Stimulation in Parkinson's Disease
Talyta Cortez Grippe, Yazan Shamli‐Oghli, Ghazaleh Darmani, Jean‐François Nankoo, Nasem Raies, Can Sarica, Tarun Arora, Carolyn A. Gunraj, Mandy Yi Rong Ding, Cricia Rinchon et al. · 2024 · Movement Disorders
Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease
Andrea Pilotto, Nicholas James Ashton, Alessandro Lupini, Beatrice Battaglio, Cinzia Zatti, Chiara Trasciatti, Stefano Gipponi, Elisabetta Cottini, Ilaria Grossi, Alessandro Salvi et al. · 2024 · Journal of Neurology
Stability and Accuracy of a Diagnosis of Parkinson Disease Over 10 Years
Valtteri Räty, Tomi Kuusimäki, Joonas Majuri, Tero J. Vahlberg, Maria Gardberg, Tommi Noponen, Marko Seppänen, Anna‐Maija Tolppanen, Valtteri Kaasinen · 2025 · Neurology
AI-driven precision diagnosis and treatment in Parkinson’s disease: a comprehensive review and experimental analysis
Bhekisipho Twala · 2025 · Frontiers in Aging Neuroscience
Current radiotracers to image neurodegenerative diseases
Solveig Tiepolt, Marianne Patt, Gayanè Aghakhanyan, Philipp Meyer, Swen Hesse, Henryk Barthel, Osama Sabri · 2019 · EJNMMI Radiopharmacy and Chemistry
Elemental fingerprint: Reassessment of a cerebrospinal fluid biomarker for Parkinson's disease
Fabian Maass, Bernhard Michalke, Desiree Willkommen, Andreas Leha, Claudia Schulte, Lars Tönges, Brit Mollenhauer, Claudia Trenkwalder, Daniel Rückamp, Matthias Börger et al. · 2019 · Neurobiology of Disease
The Neuropsychological Profile of Mild Cognitive Impairment in Lewy Body Dementias
Joanna Ciafone, Bethany Little, Alan J. Thomas, Peter Gallagher · 2019 · Journal of the International Neuropsychological Society
Differential diagnosis of parkinsonian syndromes: a comparison of clinical and automated - metabolic brain patterns’ based approach
Tomaž Rus, Petra Tomše, Luka Jensterle, Marko Grmek, Zvezdan Pirtošek, David Eidelberg, Chris C. Tang, Maja Trošt · 2020 · European Journal of Nuclear Medicine and Molecular Imaging
The Pathophysiological Correlates of Parkinson's Disease Clinical Subtypes
Daniele Belvisi, Andrea Fabbrini, Maria Ilenia De Bartolo, Matteo Costanzo, Nicoletta Manzo, Giovanni Fabbrini, Giovanni Defazio, Antonella Conte, Alfredo Berardelli · 2020 · Movement Disorders
Resting-state EEG alpha/theta ratio related to neuropsychological test performance in Parkinson’s Disease
Alberto Jaramillo-Jiménez, Jazmín Ximena Suárez-Revelo, John Fredy Ochoa-Gómez, Jairo Alexander Carmona Arroyave, Yamile Bocanegra, Francisco Javier Lopera, Omar Buriticá, David Antonio Pineda-Salazar, Leonardo Moreno Gómez, Carlos Tobón et al. · 2021 · Clinical Neurophysiology
Effect of diabetes control status on the progression of Parkinson’s disease: A prospective study
Ruwei Ou, Qianqian Wei, Yanbing Hou, Lingyu Zhang, Kuncheng Liu, Junyu Lin, Zheng Jiang, Wei Song, Bei Cao, Huifang Shang · 2021 · Annals of Clinical and Translational Neurology
Detection of Dermal Alpha-Synuclein Deposits as a Biomarker for Parkinson’s Disease
Kathrin Doppler · 2021 · Journal of Parkinson s Disease
Evidence for Peripheral Immune Activation in Parkinson’s Disease
Xueping Chen, Weihua Feng, Ruwei Ou, Jiao Liu, Jing Yang, Jiajia Fu, Bei Cao, Yongping Chen, Qianqian Wei, Huifang Shang · 2021 · Frontiers in Aging Neuroscience
Peripheral Clock System Abnormalities in Patients With Parkinson’s Disease
Tianbai Li, Cheng Cheng, Congcong Jia, Yue Leng, Qian Jin, Hang Yu, Yufei Liu, Nanxing Wang, Yuting Yang, Murad Al‐Nusaif et al. · 2021 · Frontiers in Aging Neuroscience
Safety and Efficacy of Mevidalen in Lewy Body Dementia: A Phase 2, Randomized, Placebo‐Controlled Trial
Kevin Biglan, Leanne M. Munsie, Kjell A. Svensson, Paul A. Ardayfio, Melissa Pugh, John Randall Sims, Mirosław Bryś · 2021 · Movement Disorders
Motor Progression and Nigrostriatal Neurodegeneration in Parkinson Disease
Koji Furukawa, Atsushi Shima, Daisuke Kambe, Akira Nishida, Ikko Wada, Haruhi Sakamaki‐Tsukita, Kenji Yoshimura, Yuta Terada, Yusuke Sakato, Masahiro Mitsuhashi et al. · 2022 · Annals of Neurology
Mapping Cholinergic Synaptic Loss in Parkinson’s Disease: An [18F]FEOBV PET Case-Control Study
Jacob Horsager, Niels Okkels, Allan K. Hansen, Malene Flensborg Damholdt, Katrine H. Andersen, Tatyana Dmitrievna Fedorova, Ole Lajord Munk, Erik Hvid Danielsen, Nicola Pavese, David James Brooks et al. · 2022 · Journal of Parkinson s Disease
Is there evidence of bradykinesia in essential tremor?
Bologna, M., Paparella, G., Colella, D., Cannavacciuolo, A., Angelini, L., Alunni‐Fegatelli, D., Guerra, A., Berardelli, A. · 2020 · European Journal of Neurology
Psychometrics and diagnostics of the Italian version of the Beck Depression Inventory-II (BDI-II) in Parkinson’s disease
Gianpaolo Maggi, Alfonsina D’Iorio, Edoardo Nicolò Aiello, Barbara Poletti, Nicola Ticozzi, Vincenzo Silani, Marianna Amboni, Carmine Vitale, Gabriella Santangelo · 2023 · Neurological Sciences
A vision of 14 T MR for fundamental and clinical science
Steve Bates, Serge Olaf Dumoulin, Paul J. M. Folkers, Elia Formisano, Rainer Goebel, Aidin Haghnejad, Rick C. G. Helmich, Dennis W. J. Klomp, Anja G. van der Kolk, Yi Li et al. · 2023 · Magnetic Resonance Materials in Physics Biology and Medicine
Fluid and Biopsy Based Biomarkers in Parkinson's Disease
David G. Coughlin, David John Irwin · 2023 · Neurotherapeutics
Serum and Exosomal miR-7-1-5p and miR-223-3p as Possible Biomarkers for Parkinson’s Disease
Lorenzo Agostino Citterio, Roberta Mancuso, Simone Agostini, Mario Meloni, Mario Clerici · 2023 · Biomolecules
Therapeutic effects of phlorotannins in the treatment of neurodegenerative disorders
Sarah Y. Kwon, Oh Ig Kwon, Hye Jeong Hwang, Hyeon‐Cheol Shin, Sungchil Yang · 2023 · Frontiers in Molecular Neuroscience
Mesenchymal Stem Cell-Derived Extracellular Vesicles: An Emerging Diagnostic and Therapeutic Biomolecules for Neurodegenerative Disabilities
Mahmoud K Kandeel, Mohamed Aly Morsy, Khalid M. Alkhodair, Sameer Alhojaily · 2023 · Biomolecules
Physical activity and neurotrophic factors as potential drivers of neuroplasticity in Parkinson's Disease: A systematic review and meta-analysis.
Rossella Rotondo, Stefania Proietti, M. Perluigi, E. Padua, F. Stocchi, Massimo Fini, V. Stocchi, Daniele Volpe, M. F. De Pandis · 2023 · Ageing Research Reviews
The clinical diagnosis of Parkinson's disease
Renato P. Munhoz, Vítor Tumas, José Luiz Pedroso, Laura Silveira‐Moriyama · 2024 · Arquivos de Neuro-Psiquiatria
Association of Misfolded α-Synuclein Derived from Neuronal Exosomes in Blood with Parkinson’s Disease Diagnosis and Duration
Eva Schaeffer, Annika Kluge, Claudia Schulte, Christian Deuschle, Josina Bunk, Julius Welzel, Walter Maetzler, Daniela Berg · 2024 · Journal of Parkinson s Disease
Glymphatic system dysfunction and risk of clinical milestones in patients with Parkinson disease
Cheng Yu Zhou, Xianchen Jiang, Xiaojun Guan, Tao Guo, Jingjing Wu, Haoting Wu, Chenqing Wu, Jingwen Chen, Jiaqi Wen, Sijia Tan et al. · 2024 · European Journal of Neurology
Unravelling the nonmotor mysteries of Parkinson disease
К. Ray Chaudhuri, Anna Sauerbier · 2015 · Nature Reviews Neurology
Metacognitive knowledge of olfactory dysfunction in Parkinson’s disease
Theresa Leslie White, Abbas F. Sadikot, Jelena Djordjevic · 2016 · Brain and Cognition
Earlier Intervention with Deep Brain Stimulation for Parkinson’s Disease
Gerson Suarez‐Cedeño, Jessika Suescun, Mya Caryn Schiess · 2017 · Parkinson s Disease
Linagliptin potentiates the effect of l-dopa on the behavioural, biochemical and immunohistochemical changes in experimentally-induced Parkinsonism: Role of toll-like receptor 4, TGF-β1, NF-κB and glucagon-like peptide 1
Ahmed M. Kabel, Mohamed S. Omar, A. Alhadhrami, Salman S. Alharthi, Majed Alrobaian · 2018 · Physiology & Behavior
Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease
Franziska Hopfner, Mette Wod, Günter U. Höglinger, Morten Blaabjerg, Thomas W. Rösler, Gregor Kuhlenbäumer, Kaare Christensen, Günther Deuschl, Anton Pottegård · 2019 · Neurology
Bipolar disorder and risk of Parkinson disease
Mao‐Hsuan Huang, Chih‐Ming Cheng, Kai‐Lin Huang, Ju-Wei Hsu, Ya‐Mei Bai, Tung‐Ping Su, Cheng‐Ta Li, Shih‐Jen Tsai, Wei-Chen Lin, Tzeng‐Ji Chen et al. · 2019 · Neurology
Altered sensorimotor cortex noradrenergic function in idiopathic REM sleep behaviour disorder – A PET study
Katrine B. Andersen, Allan K. Hansen, Michael Sommerauer, Tatyana Dmitrievna Fedorova, Karoline Knudsen, Kim Vang, Nathalie Van Den Berge, Martin Byskov Kinnerup, Adjmal Nahimi, Nicola Pavese et al. · 2020 · Parkinsonism & Related Disorders
Distinct Autoimmune Anti-α-Synuclein Antibody Patterns in Multiple System Atrophy and Parkinson’s Disease
Jonas Folke, Rasmus Rydbirk, Annemette Løkkegaard, Lisette Salvesen, Anne‐Mette Hejl, Charlotte Starhof, Sára Bech, Kristian Winge, Søren Christensen, Lars Østergaard Pedersen et al. · 2019 · Frontiers in Immunology
Clinical features of Lewy body dementia: insights into diagnosis and pathophysiology
Elie Matar, Kaylena A. Ehgoetz Martens, Glenda Margaret Halliday, Simon J.G. Lewis · 2019 · Journal of Neurology
Plasma Cytokines Profile in Patients with Parkinson’s Disease Associated with Mutations in GBA Gene
Irina V. Miliukhina, T. Usenko, Konstantin A. Senkevich, Mikhail A. Nikolaev, Alla Timofeeva, Elizaveta A. Agapova, А. В. Семенов, N. E. Lubimova, A. A. Totolyan, С. Н. Пчелина · 2020 · Bulletin of Experimental Biology and Medicine
Quantification of tremor using consumer product accelerometry is feasible in patients with essential tremor and Parkinson’s disease: a comparative study
Emilie M.J. van Brummelen, Dimitrios Ziagkos, Wadim M. I. de Boon, Ellen P. Hart, Robert Jan Doll, Teppo Huttunen, Petteri Kolehmainen, Geert Jan Groeneveld · 2020 · Journal of Clinical Movement Disorders
Management of psychiatric disorders in Parkinson's disease
Daniel A. Weintraub · 2020 · Neurotherapeutics
Increased iron-deposition in lateral-ventral substantia nigra pars compacta: A promising neuroimaging marker for Parkinson's disease
Naying He, Jason A. Langley, Daniel E. Huddleston, Shengdi Chen, Pei Huang, Huawei Ling, Fuhua Yan, Xiaoping Philip Hu · 2020 · NeuroImage Clinical
Beyond Alzheimer's disease: Can bilingualism be a more generalized protective factor in neurodegeneration?
Toms Voits, Christos Pliatsikas, Holly Robson, Jason Rothman · 2020 · Neuropsychologia
Parkinsonism in children: Clinical classification and etiological spectrum
Vincenzo Leuzzi, Francesca Nardecchia, Roser Maria Pons, Serena Galosi · 2020 · Parkinsonism & Related Disorders
Association of the Plasma Long Non-coding RNA MEG3 With Parkinson's Disease
Yi Quan, Wang Jia, Shuo Wang, Jizong Zhao · 2020 · Frontiers in Neurology
Motor dysfunction in mild cognitive impairment as tested by kinematic analysis and transcranial magnetic stimulation
Donato Colella, Andrea Guerra, Giulia Paparella, Ettore Cioffi, Antonella Di Vita, Alessandro Trebbastoni, Alfredo Berardelli, Matteo Bologna · 2020 · Clinical Neurophysiology
White Matter Hyperintensities, Dopamine Loss, and Motor Deficits in De Novo Parkinson's Disease
Seong Ho Jeong, Hye Sun Lee, Jin Ho Jung, Kyoungwon Baik, Yang Hyun Lee, Han Soo Yoo, Young H. Sohn, Seok Jong Chung, Phil Hyu Lee · 2021 · Movement Disorders
Exploring the Connection between Porphyromonas gingivalis and Neurodegenerative Diseases: A Pilot Quantitative Study on the Bacterium Abundance in Oral Cavity and the Amount of Antibodies in Serum
Raffaella Franciotti, Pamela Pignatelli, Claudia Carrarini, Federica Maria Romei, Martina Mastrippolito, Antonella Gentile, Rosa Mancinelli, Stefania Fulle, Adriano Piattelli, MARCO C. ONOFRJ et al. · 2021 · Biomolecules
Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity
Nurit Omer, Nir Giladi, Tanya Gurevich, Anat Bar‐Shira, Mali Gana‐Weisz, Tal Glinka, Orly Goldstein, Meir Kestenbaum, Jesse M. Cedarbaum, Omar S. Mabrouk et al. · 2021 · Movement Disorders
Comprehensive Analysis of Brain Volume in REM Sleep Behavior Disorder with Mild Cognitive Impairment
David Rémillard-Pelchat, Shady Rahayel, Malo Gaubert, Ronald B. Postuma, Jacques Yves Montplaisir, Amélie Pelletier, Oury Monchi, Simona Maria Brambati, Julie Carrier, Jean‐François Gagnon · 2021 · Journal of Parkinson s Disease
Brain Metabolism Related to Mild Cognitive Impairment and Phenoconversion in Patients With Isolated REM Sleep Behavior Disorder
Eun Jin Yoon, Jee‐Young Lee, Heejung Kim, Dallah Yoo, Jung Hwan Shin, Hyunwoo Nam, Beomseok Jeon, Yu Kyeong Kim · 2022 · Neurology
Proof of Concept in Artificial-Intelligence-Based Wearable Gait Monitoring for Parkinson’s Disease Management Optimization
Robert Radu Ileșan, Claudia-Georgiana Cordoș, Laura-Ioana Mihăilă, Radu Fleșar, Ana-Sorina Popescu, Lăcrămioara Perju‐Dumbravă, Paul Faragó · 2022 · Biosensors
A Hybrid U-Lossian Deep Learning Network for Screening and Evaluating Parkinson’s Disease
Rytis Maskeliūnas, Robertas Damaševičius, Audrius Kulikajevas, Evaldas Padervinskis, Kipras Pribuišis, Virgilijus Uloza · 2022 · Applied Sciences
Cognitive and Neuropsychiatric Features in Parkinson's and Lewy Body Dementias
Julie A. Fields · 2017 · Archives of Clinical Neuropsychology
Thinking versus feeling: How interoception and cognition influence emotion recognition in behavioural-variant frontotemporal dementia, Alzheimer's disease, and Parkinson's disease
Hazelton, Jessica L., Fittipaldi, Sol, Fraile-Vazquez, Matias, Sourty, Marion, Legaz, Agustina, Hudson, Anna L., Cordero, Indira Garcia, Salamone, Paula C., Yoris, Adrian, Ibañez, Agustín et al. · 2023 · Cortex